Skip to main content
. Author manuscript; available in PMC: 2015 Sep 15.
Published in final edited form as: J Immunol. 2014 Aug 18;193(6):3113–3125. doi: 10.4049/jimmunol.1400820

FIGURE 7.

FIGURE 7

Extracellular neutralization. (a) Sera neutralize tissue culture adapted (TCLA) SIVmac 251, at 20 weeks at higher titer compared to 5 weeks. (b, c) Compared to pre-bleed sera, SIVmac251-32H and the challenge stock of WT SIVmac251 are partially neutralized over a broad range of dilutions, to 50% reduction in infectivity with 20-week sera.